Platelet-rich plasma to improve thin uterine lining
Part of Women’s health & pregnancy clinical trials.
This trial studies whether platelet-rich plasma (PRP) can help grow a thin uterine lining enough to support a pregnancy. It is aimed at people who have had repeated unsuccessful frozen embryo transfers and had a lining of 6 mm or less.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had at least 2 unsuccessful frozen embryo transfer cycles (or cycles canceled due to too-thin lining).
- In those prior cycles, your uterine lining measured 6 mm or less at its thickest point.
- Your most recent unsuccessful/canceled frozen embryo transfer was on or after January 1, 2017.
- You do not have certain uterine problems that may require surgery (like unrepaired defects, or untreated submucosal fibroids).
- You have no history of blood clots or inherited/acquired clotting problems, and you can sign written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether injecting platelet-rich plasma (PRP) into your ovaries can improve the quality of your embryos. You will go through two IVF cycles, and the treatment aims to help women with low embryo quality get better results.
This study tests whether placing your own platelet-rich plasma (a liquid made from your blood that helps healing) into the uterus before an embryo transfer can help the uterine lining grow thicker and improve the chances of a successful pregnancy.
This trial tests whether injecting platelet-rich plasma (a concentrate from your own blood) into the uterus or ovaries can help women with certain fertility issues, such as damaged uterine lining, scarring, or low egg reserve. It aims to improve pregnancy chances in these challenging cases.
This study tests whether platelet-rich plasma (PRP)—a concentration of healing cells from your own blood—injected into the uterus can improve the uterine lining and help embryos implant successfully during fertility treatment. Researchers will check how the treatment changes immune cells in the uterus.
This trial tests a new treatment using stem cell particles (exosomes) to help rebuild the lining of the womb in women whose lining is too thin after surgery for scar tissue. It may improve chances of success with IVF.
This study tests if a special treatment made from cord blood can help women with a thin uterine lining (the inner layer of the womb) or Asherman syndrome (scar tissue). The goal is to see if it can improve the lining so it's healthier for pregnancy.
Hear when a new Infertility of Uterine Origin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.